Shockwave Medical saw the highest growth of 199% in patent filings in December and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 132% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Shockwave Medical‘s patent filings and grants. Buy the databook here.
Shockwave Medical has been focused on protecting inventions in United States(US) with ten publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 67% grants. The United States(US), European Patent Office(EPO), Australia(AU), and China(CN) patent Office are among the top ten patent offices where Shockwave Medical is filings its patents. Among the top granted patent authorities, Shockwave Medical has 67% of its grants in United States(US), 17% in European Patent Office(EPO) and 17% in Australia(AU).
AbbVie and SANUWAVE Health could be the strongest competitors for Shockwave Medical
General surgery devices related patents lead Shockwave Medical portfolio followed by cardiovascular devices
Shockwave Medical has highest number of patents in general surgery devices followed by cardiovascular devices. For general surgery devices, nearly 67% of patents were filed and 67% of patents were granted in Q4 2023.
For comprehensive analysis of Shockwave Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.